IL6 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, OSO2% substantially alleviated the CML-induced IL-6 production apparent by a diminished IHC stained area (11.7%) that is significantly 1.4-fold (p = 0.02) and 1.5-fold (p < 0.03) lower than the IHC stained area for only CML and CML+SO2% injected groups, asserting the impact of OSO2% on IL-6 production.